Development of an in-house quantitative elisa for the evaluation of different covid-19 vaccines in humans

HIGHLIGHTS

• who: Mariem Gdoura from the The ongoing global pandemic of coronavirus disease , (COVID-19) is caused by the Severe Acute Respiratory Syndrome Coronavirus , (SARS-CoV-2), identified for the first time in December , in Wuhan, ChinaUniversity of have published the paper: Development of an in-house quantitative ELISA for the evaluation of different Covid-19 vaccines in humans, in the Journal: Scientific Reports Scientific Reports of 23/Dec/2021
• how: In the analysis when the authors have high anti-N Elecsys titres of Coronavax and Sinopharm they are considered previously infected by SARS-CoV-2 . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.